FolioLanternBeta
MPLTMapLight Therapeutics, Inc.

Robert Malenka

Director at MapLight Therapeutics, Inc., as of Apr 17, 2026Sold $1.6M of stock in the past 12 months: 14% under a disclosed plan and 86% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
83K
shares sold, past 12 months
12
days with sales
$394K
largest single day, Jan 29, 2026
1
company filed for

Share of stake sold and shares held at MapLight Therapeutics, Inc. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $636K to cover taxesJanFeb 2026: $732K to cover taxes$732KFebMarApr 2026: $231K under a disclosed planAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
MapLight Therapeutics, Inc. (MPLT)DirectorOct 27, 2025Apr 17, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.